AIFA and Ethical MedTech
Official Italian Agency for AIFA submissions:
According to Italian legislation, any marketing authorization holder or pharmaceutical company responsible for the commercialization of a drug, which organizes or helps to organize – whether by direct or indirect funding in Italy or abroad – a congress, or a meeting on topics in any way related to the use of medicines, shall notify the competent unit of the Italian Medicines Agency (AIFA) at least 60 days before the date of the event. This is to ensure adherence to strict technical criteria and to provide further knowledge in the fields of chemistry, pharmaceutical technology, biochemistry, physiology, pathology and clinical medicine.
Duerre Congressi srl has been appointed as the official agency for AIFA submission to support sponsors and exhibitors with these formalities. Pharmaceutical companies which require the authorization from AIFA are advised to contact before July 31 2021:
ABC6 is compliant with the MedTech Europe Code of Ethical Business Practice.